Quoin Pharmaceuticals, Ltd
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
70.3M
on 2026-06-30, from 3.80M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
None
No at-the-market programme on file in the last 30 months.
Warrants
The 10-Q filed 2026-08-14 is not read yet.
Cash
2.8 quarters
$10.8M on 2026-06-30 ÷ $3.8M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-10-10 | Private placement | not read | not read | $16.6M | 8-K ↗ |
| 2024-12-20 | Public offering incl. 11.97M pre-funded, with warrants at $0.45 | 15,111,110 | $0.45 | $6.8M | 424B4 ↗ |
Also on file: a 1-for-20 reverse split, 2025-04-08 8-K ↗ · a 1-for-35 reverse split, 2025-04-09 8-K ↗